Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 497 of 1,261
  1. US 2019153441

    MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA

    CASEBIA THERAPEUTICS LLP [GB] · Granted May 23, 2019 · Expires May 18, 2039

    granted
  2. US 2019151500

    OPHTHALMIC VISCOELASTIC COMPOSITIONS

    BAUSCH & LOMB [US] · Granted May 23, 2019 · Expires May 18, 2039

    granted
  3. EP 3485879

    ORALE PHARMAZEUTISCHE FORMULIERUNG ENTHALTEND BAKTERIEN

    MAAT PHARMA [FR] · Granted May 22, 2019 · Expires May 17, 2039

    granted
  4. US 10293002

    Methods and compositions for in vivo induction of pancreatic beta cell formation

    The Board of Regents of the University of Texas System · Granted May 21, 2019 · Expires May 16, 2039

    granted
  5. US 10293077

    Polyphosphate-functionalized inorganic nanoparticles as hemostatic compositions and methods of use

    The Regents of the University of California · Granted May 21, 2019 · Expires May 16, 2039

    granted
  6. US 10293037

    DNA vaccine for use in pancreatic cancer patients

    Vaximm AG · Granted May 21, 2019 · Expires May 16, 2039

    granted
  7. US 10294296

    Treatment for neoplastic diseases

    XBIOTECH INC. · Granted May 21, 2019 · Expires May 16, 2039

    granted
  8. US 10294277

    Stabilised FMDV capsids

    The Pirbright Institute · Granted May 21, 2019 · Expires May 16, 2039

    granted
  9. US 10294474

    Targeting ligands

    Arrowhead Pharmaceuticals, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted
  10. US 10293080

    Ionic liquids that sterilize and prevent biofilm formation in skin wound healing devices

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted May 21, 2019 · Expires May 16, 2039

    granted
  11. US 10294483

    Eimeria tenella elongation factor-1 alpha recombinant immunogenic compositions which induce active protective immunity against avian coccidiosis

    The United States of America, as represented by the Secretary of Agriculture · Granted May 21, 2019 · Expires May 16, 2039

    granted
  12. US 10293056

    Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases

    The Board of Regents of the University of Texas System · Granted May 21, 2019 · Expires May 16, 2039

    granted
  13. US 10293005

    Use of gram negative species to treat atopic dermatitis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 21, 2019 · Expires May 16, 2039

    granted
  14. US 10294477

    Compositions and methods for modulating PKK expression

    Ionis Pharmaceuticals, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted
  15. US 10292992

    Selective high-affinity polydentate ligands and methods of making such

    The Regents of the University of California · Granted May 21, 2019 · Expires May 16, 2039

    granted
  16. US 10293000

    Methods and compositions for the treatment of lysosomal storage diseases

    Sangamo Therapeutics, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted
  17. US 10292986

    Methods for treating epithelian mesenchymal transition related diseases

    The Board of Regents of the University of Texas System · Granted May 21, 2019 · Expires May 16, 2039

    granted
  18. US 10292979

    Methods of treating cancer patients with farnesyltransferase inhibitors

    Kura Oncology, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted
  19. US 10292951

    Methods and compositions for treating conditions associated with an abnormal inflammatory responses

    First Wave Bio, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted
  20. US 10294274

    Polypeptide ligands specific for plasma kallikrein

    BicycleRD Limited · Granted May 21, 2019 · Expires May 16, 2039

    granted
  21. US 10292971

    Tetrahydro-1H-pyrido[3,4-b]indole anti-estrogenic drugs

    Olema Pharmaceuticals, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted
  22. US 10292940

    Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof

    BrightGene Bio-Medical Technology Co., Ltd. · Granted May 21, 2019 · Expires May 16, 2039

    granted
  23. US 10293022

    Peptide inhibitors of serotonin 5-HT2C receptor:PTEN interaction

    THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYTEM · Granted May 21, 2019 · Expires May 16, 2039

    granted
  24. US 10293012

    Methods of using extracts of melissa officinalis against filoviruses

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 21, 2019 · Expires May 16, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.